Subscribe to Newsletter

Trends & Forecasts

Discovery & Development Clinical Trials

Making Clinical Trials Family Friendly

| Katherine Seay | 4 min read

Can making clinical trials more family friendly help increase the number of female participants?

Business & Regulation Business Practice

Breaking Down Brain Barriers

| Agnese Cattaneo | 3 min read

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

Business & Regulation Trends & Forecasts

This Week’s Biopharma News: Roche’s $50 Billion Investment in the US and More

| 4 min read

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

Business & Regulation Trends & Forecasts

Quality Over Quantity: EMA's New Approach to Biosimilars

| Rob Coker | 2 min read

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Business & Regulation Standards & Regulation

Trump's New Push on Drug Pricing

| Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Business & Regulation Standards & Regulation

Disrupted Development

| Rob Coker | 3 min read

The political situation in the US and its impact on science and medicine is changing rapidly. Here’s a quick look at the latest developments.

Business & Regulation Standards & Regulation

Sitting Down With… The Past: Kowid Ho

| 3 min read

We dive into the archive of 2022 for insight and inspiration – this time with Kowid Ho

Business & Regulation Trends & Forecasts

Predictions for Pharma’s Future

| 4 min read

Looking ahead to the next 5–10 years, what will be the key disruptors and/or what can be improved upon in the pharma industry?

Business & Regulation Trends & Forecasts

The Economics of Biosimilars

| Stephanie Vine | 7 min read

We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US.

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.


Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register